Kalpana Gupta Shekhawat: A Practical Clinical Approach to Iron Regulation
Kalpana Gupta Shekhawat, Chairperson at the Functional and Metabolic Medicine Academy, Gurugram, India, shared a post on LinkedIn:
“Balancing Ferritin Levels: A Practical Clinical Approach to Iron Regulation
Ferritin is one of the most commonly used markers to assess iron status, yet it is often misinterpreted when evaluated in isolation.
While ferritin reflects iron storage, it is also influenced by inflammation, liver function, metabolic health, and the body’s regulation of iron metabolism.
For this reason, ferritin should always be interpreted in the context of other laboratory markers and the patient’s clinical presentation.
A proper evaluation of iron status typically includes ferritin alongside hemoglobin, mean corpuscular volume (MCV), red cell distribution width (RDW), serum iron, transferrin saturation (TSAT), and inflammatory markers such as C-reactive protein (CRP).
Reviewing these parameters together helps distinguish between true iron deficiency, inflammation-related ferritin elevation, and possible iron overload.
Low ferritin is one of the most reliable indicators of iron deficiency, often seen when levels fall below approximately 30 ng/mL.
However, identifying the underlying cause is essential.
Iron deficiency may result from inadequate dietary intake, chronic blood loss, gastrointestinal infections such as Helicobacter pylori,malabsorption disorders like celiac disease, low gastric acid, or long-term proton pump inhibitor use.
In many cases, impaired absorption rather than low intake is the key contributor.
Management therefore begins with addressing the underlying cause.
When supplementation is required, selecting an appropriate iron preparation, avoiding calcium at the time of dosing, and pairing iron with vitamin C can help improve absorption.
Follow-up testing after six to eight weeks is recommended to monitor response.
Elevated ferritin does not always indicate excess iron.
Because ferritin is an acute-phase reactant, it can increase in conditions such as chronic inflammation, liver dysfunction, infections, and metabolic syndrome.
In such cases, addressing the underlying metabolic or inflammatory drivers is essential.
Ultimately, the clinical goal is not simply raising or lowering ferritin but restoring balanced iron regulation within the body.”

See more in the gallery.
Stay updated with Hemostasis Today.
-
Nov 14, 2026, 23:57Jamie S. Y. Ho: Exploring the Mechanisms of Arterial Thrombosis and the Evolution of Antithrombotic Therapy
-
Nov 14, 2026, 23:53Jacopo Imberti: The Past, Present and Future of Arterial Thrombosis Research
-
Nov 14, 2026, 23:48Shrouk Ramadan: Joining the Editorial Review Board of Clinical and Applied Thrombosis and Hemostasis
-
Nov 14, 2026, 23:46Habib Bennaceur: Moving Towards Fewer Limitations for People Living With Haemophilia
-
Nov 14, 2026, 23:44Paul Healy: EU Approves Frehemgo for Haemophilia A
-
Nov 14, 2026, 23:43Mehak Trehan: ASH 2026 Benign Hematology – Ten Abstracts Through an Indian Lens
-
Nov 14, 2026, 23:33Felipe Magalhaes Furtado: Artificial Intelligence Advances PNH Clone Detection Through Machine Learning
-
Nov 14, 2026, 23:33Mona Alfaraj: International Pathology Day Promotes Education in Hemoglobinopathy Diagnostics
-
Nov 14, 2026, 23:33Alexandros Makis: Exploring Vascular Mechanisms and Therapeutic Targets in β-Thalassemia